Browse by all authors Browse By Author Name - Cannell,+Paul

Browse Results (5 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Hertzberg, Mark, Matthews, Jane Palfrey, Stone, Janey Malka, Dubosq, Ming-Celine, Grigg, Andrew, Ellis, David, Benson, Warwick, Browett, Peter, Horvath, Noemi, Januszewicz, Henry, Abdi, Ehtesham, Green, Michael, Bonaventura, Anthony, Marlton, Paula, Cannell, Paul and Wolf, Max (2014) A phase III randomized trial of high-dose CEOP+filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial. American Journal of Hematology, 89 5: 536-541. doi:10.1002/ajh.23684 20   0 Cited 0 times in Scopus0 0
Mollee, Peter, Tiley, Campbell, Cunningham, Ilona, Moore, John, Prince, Miles, Cannell, Paul, Gibbons, Steve, Tate, Jill, Paul, Sanjoy and Gill, Devinder S. (2011). A Phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis. In: ASH Annual Meeting Abstracts 2011. 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH), San Diego, CA, United States, (1700-1700). Dec 10-13, 2011. 38   0
Mollee, Peter, Tiley, Campbell, Cunningham, Ilona, Moore, John, Prince, H.Miles, Cannell, Paul, Gibbons, Steve, Tate, Jill, Paul, Sanjoy, Fan, Helen Mar and Gill, Devinder S. (2012) A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis. British Journal of Haematology, 157 6: 766-769. doi:10.1111/j.1365-2141.2012.09080.x 57   3 Cited 3 times in Scopus3 1
Snowden, John A., Passweg, Jakob, Moore, John J., Milliken, Sam, Cannell, Paul, Van Laar, Jacob, Verburg, Robert, Szer, Jeffrey, Taylor, Kerry, Joske, David, Rule, Simon, Bingham, Sarah J., Emery, Paul, Burt, Richard K., Lowenthal, Raymond M., Durez, Patrick., McKendry, Robert J., Pavletic, Steven Z., Espigado, Ildefonso, Jantunen, Esa, Kashyap, Ashwin, Rabusin, Marco, Brooks, Peter, Bredeson, Christopher and Tyndall, Alan (2004) Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: A report from the EBMT and ABMTR. Journal of Rheumatology, 31 3: 482-488. 262   82 Cited 116 times in Scopus116
Richardson, Paul G., Spencer, Andrew, Cannel, Paul, Harrison, Simon J., Catley, Laurence, Underhill, Craig, Zimmerman, Todd M., Hofmeister, Craig C., Jakubowiak, Andrzej J., Laubach, Jacob P., Palladino, Michael A., Longenecker, Angie M., Lay, Ana, Wear, Sandra, Lloyd, G. Kenneth, Hannah, Alison L., Reich, Steve, Spear, Matthew A. and Anderson, Kenneth C. (2011). Phase 1 Clinical Evaluation of Twice-Weekly Marizomib (NPI-0052), a Novel Proteasome Inhibitor, in Patients with Relapsed/Refractory Multiple Myeloma (MM). In: Blood. 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego Ca, (140-141). Dec 10-13, 2011. 74   0